Log In
Print this Print this

Molecule targeting prostate cancer

  Manage Alerts
Collapse Summary General Information
Company Jubilant Life Sciences Ltd.
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentIND
Standard IndicationProstate cancer
Indication DetailsTreat prostate cancer
Regulatory Designation
PartnerEndo International plc

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today